Results 241 to 250 of about 1,094,070 (306)

Correction: Zeng et al. Hedgehog Signaling: Linking Embryonic Lung Development and Asthmatic Airway Remodeling. <i>Cells</i> 2022, <i>11</i>, 1774. [PDF]

open access: yesCells
Zeng LH   +12 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Pharmacology

International Anesthesiology Clinics, 1999
When performing IVCS, one must never forget the primary goal of providing patient comfort without compromising cardiopulmonary function or the patient's ability to react purposely to verbal commands and physical stimuli. When it is anticipated that required sedation will lead to loss of protective airway reflexes, such patients require a greater level ...
K P, Lewis, G D, Stanley
openaire   +2 more sources

The Pharmacology of Tramadol

Drugs, 1994
(+/-)-Tramadol is a central analgesic with low affinity for opioid receptors. The rate of production of its M1 metabolite (O-demethyl tramadol) is influenced by debrisoquine-type polymorphism, and this metabolite shows a higher affinity for opioid receptors than the parent drug.
Dayer, P   +2 more
openaire   +3 more sources

PHARMACOLOGY OF PYRAZOLOPYRIDINES

Clinical Neuropharmacology, 1984
Pyrazolopyridines (PZP's) in general represent a chemically unique class of non-sedative anxiolytic agents. Tracazolate (ICI 136,753) is a member of pyrazolopyridine series that has shown anxiolytic properties in animal models. Tracazolate demonstrates a wider separation between sedative and therapeutic doses than do benzodiazepines.
J B, Patel   +3 more
openaire   +2 more sources

Pharmacology of Ifosfamide

Oncology, 2003
Ifosfamide is a bifunctional alkylating agent, used as a racemic mixture by intravenous route in the treatment of various tumors. It is an oxazaphosphorine derivative with a structural formula similar to that of cyclophosphamide. As a prodrug it requires activation in the liver by a cytochrome mixed-function oxidase system.
FRANCESCHI, Loretta, FURLANUT, Mario
openaire   +3 more sources

Home - About - Disclaimer - Privacy